Literature DB >> 12031645

Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure.

Leslie S Kean1, Laura E Brown, J Wylie Nichols, Narla Mohandas, David R Archer, Lewis L Hsu.   

Abstract

OBJECTIVES: 1). To study the mechanisms of anemia, erythroid hyperplasia, and red blood cell (RBC) clearance in murine models of sickle cell disease (Sickle) and beta-thalassemia (Th1/Th1); 2) To determine the contribution of the phospholipid scramblase enzyme to phosphatidylserine (PS) exposure and RBC death in Sickle and Th1/Th1 mice.
METHODS: We used a combination of flow-cytometric analysis and assays for phospholipid remodeling to determine the extent and sites of erythroid hyperplasia, PS exposure, and cell death.
RESULTS: 1) Sickle RBCs have a much shorter half-life than Th1/Th1 RBCs (0.8 days vs. 11 days). A significant proportion of Th1/Th1 peripheral reticulocytes mature into erythrocytes, however, approximately fivefold fewer Sickle reticulocytes mature. While erythroid hyperplasia exists in both Sickle and Th1/Th1 mice, Th1/Th1 produce fourfold more RBCs than necessary to maintain steady state, while Sickle produce no excess RBCs. 2) 61% of Sickle and 34% of Th1/Th1 RBCs are scramblase(+) as measured by internalization assays of the fluorescent phospholipid NBD-PC. The majority of NBD-PC(+) RBCs are also annexin-V(+), supporting a mechanistic link between scramblase activity and PS exposure. A proportion of both reticulocytes and older RBCs in Sickle and Th1/Th1 mice have active scramblase, and the degree of scramblase activation in these strains correlates with the propensity for RBC death.
CONCLUSIONS: Sickle and Th1/Th1 mice are both anemic, with significant erythroid hyperplasia. Th1/Th1 mice display ineffective erythropoiesis while Sickle mice show rapid peripheral destruction of RBCs. PS exposure and phospholipid scramblase activity serve as markers of RBCs with altered phospholipid asymmetry and greater propensity for cell death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031645     DOI: 10.1016/s0301-472x(02)00780-4

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  23 in total

Review 1.  Cation channels, cell volume and the death of an erythrocyte.

Authors:  Florian Lang; Karl S Lang; Thomas Wieder; Svetlana Myssina; Christina Birka; Philipp A Lang; Stephanie Kaiser; Daniela Kempe; Christophe Duranton; Stephan M Huber
Journal:  Pflugers Arch       Date:  2003-08-07       Impact factor: 3.657

2.  Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.

Authors:  Ilaria V Libani; Ella C Guy; Luca Melchiori; Raffaella Schiro; Pedro Ramos; Laura Breda; Thomas Scholzen; Amy Chadburn; YiFang Liu; Margrit Kernbach; Bettina Baron-Lühr; Matteo Porotto; Maria de Sousa; Eliezer A Rachmilewitz; John D Hood; M Domenica Cappellini; Patricia J Giardina; Robert W Grady; Johannes Gerdes; Stefano Rivella
Journal:  Blood       Date:  2008-05-14       Impact factor: 22.113

Review 3.  Regulation of leucocyte homeostasis in the circulation.

Authors:  Christoph Scheiermann; Paul S Frenette; Andrés Hidalgo
Journal:  Cardiovasc Res       Date:  2015-03-05       Impact factor: 10.787

Review 4.  Of membranes and malaria: phospholipid asymmetry in Plasmodium falciparum-infected red blood cells.

Authors:  Merryn Fraser; Kai Matuschewski; Alexander G Maier
Journal:  Cell Mol Life Sci       Date:  2021-03-13       Impact factor: 9.261

5.  Evidence for ineffective erythropoiesis in severe sickle cell disease.

Authors:  Catherine J Wu; Lakshamanan Krishnamurti; Jeffery L Kutok; Melinda Biernacki; Shelby Rogers; Wandi Zhang; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

6.  Beneficial effect of aurothiomalate on murine malaria.

Authors:  Ioana Alesutan; Diwakar Bobbala; Syed M Qadri; Adriana Estremera; Michael Föller; Florian Lang
Journal:  Malar J       Date:  2010-05-07       Impact factor: 2.979

7.  Adenosine monophosphate deaminase 3 activation shortens erythrocyte half-life and provides malaria resistance in mice.

Authors:  Elinor Hortle; Brunda Nijagal; Denis C Bauer; Lora M Jensen; Seong Beom Ahn; Ian A Cockburn; Shelley Lampkin; Dedreia Tull; Malcolm J McConville; Brendan J McMorran; Simon J Foote; Gaetan Burgio
Journal:  Blood       Date:  2016-07-27       Impact factor: 22.113

8.  Humanized Mouse Model of Cooley's Anemia.

Authors:  Yongliang Huo; Sean C McConnell; Shan-Run Liu; Rui Yang; Ting-Ting Zhang; Chiao-Wang Sun; Li-Chen Wu; Thomas M Ryan
Journal:  J Biol Chem       Date:  2008-12-19       Impact factor: 5.157

9.  Transferrin therapy ameliorates disease in beta-thalassemic mice.

Authors:  Huihui Li; Anne C Rybicki; Sandra M Suzuka; Leni von Bonsdorff; William Breuer; Charles B Hall; Z Ioav Cabantchik; Eric E Bouhassira; Mary E Fabry; Yelena Z Ginzburg
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440

10.  Mice deficient in the putative phospholipid flippase ATP11C exhibit altered erythrocyte shape, anemia, and reduced erythrocyte life span.

Authors:  Mehmet Yabas; Lucy A Coupland; Deborah Cromer; Markus Winterberg; Narci C Teoh; James D'Rozario; Kiaran Kirk; Stefan Bröer; Christopher R Parish; Anselm Enders
Journal:  J Biol Chem       Date:  2014-06-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.